Smith & Nephew SNATS (NYSE:SNN) Sets New 1-Year Low – Time to Sell?

Smith & Nephew SNATS, Inc. (NYSE:SNN – Get Free Report) reached a new 52-week low on Thursday. The company traded as low as $26.38 and last traded at $26.4550, with a volume of 588841 shares changing hands. The stock had previously closed at $26.96.

Analysts Set New Price Targets

Several research analysts have commented on the company. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Smith & Nephew SNATS in a report on Thursday, August 6th. Weiss Ratings cut Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, September 24th. Zacks Research upgraded Smith & Nephew SNATS from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 8th. Wall Street Zen raised Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a research note on Sunday, September 13th. Finally, Barclays lowered Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $31.91.

Check Out Our Latest Report on SNN

Smith & Nephew SNATS Trading Down 0.5%

The company has a current ratio of 2.14, a quick ratio of 1.11 and a debt-to-equity ratio of 0.62. The business has a fifty day simple moving average of $28.99 and a 200-day simple moving average of $30.35.

Smith & Nephew SNATS Dividend Announcement

The business also recently declared a dividend, which will be paid on Friday, November 6th. Shareholders of record on Friday, October 2nd will be issued a $0.3120 dividend. This represents a yield of 236.0%. The ex-dividend date is Friday, October 2nd.

Hedge Funds Weigh In On Smith & Nephew SNATS

Several institutional investors have recently made changes to their positions in SNN. Equity Investment Corp grew its position in Smith & Nephew SNATS by 3.9% in the 4th quarter. Equity Investment Corp now owns 7,502 shares of the medical equipment provider’s stock valued at $246,000 after purchasing an additional 285 shares during the period. Parallel Advisors LLC increased its stake in Smith & Nephew SNATS by 20.0% during the 1st quarter. Parallel Advisors LLC now owns 2,322 shares of the medical equipment provider’s stock valued at $74,000 after purchasing an additional 387 shares in the last quarter. Clearstead Trust LLC acquired a new position in Smith & Nephew SNATS during the second quarter worth $25,000. BKM Wealth Management LLC raised its holdings in Smith & Nephew SNATS by 2.5% during the first quarter. BKM Wealth Management LLC now owns 18,462 shares of the medical equipment provider’s stock worth $587,000 after buying an additional 451 shares during the last quarter. Finally, Ritholtz Wealth Management lifted its stake in shares of Smith & Nephew SNATS by 6.0% in the first quarter. Ritholtz Wealth Management now owns 11,157 shares of the medical equipment provider’s stock valued at $355,000 after buying an additional 633 shares in the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

About Smith & Nephew SNATS

(Get Free Report)

Smith & Nephew plc is a global medical technology company headquartered in Watford, England. Founded in 1856 by pharmacist Thomas James Smith in Hull, the company has grown from a pharmacy business into a provider of surgical and wound-care products for healthcare professionals and patients.

The company operates through three principal areas: Orthopaedics, Sports Medicine, and Advanced Wound Management. Its products include joint-replacement systems, trauma and extremity devices, arthroscopy equipment, surgical repair technologies, wound dressings, negative-pressure wound therapy systems, and other products used to support healing and tissue recovery.

Smith & Nephew serves hospitals, clinics, surgeons, and patients in markets around the world, with operations and commercial activities spanning North America, Europe, Asia-Pacific, and other international regions.

Further Reading

Receive News & Ratings for Smith & Nephew SNATS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS and related companies with MarketBeat.com's FREE daily email newsletter.